Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BGB-3111 in Healthy Males

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

April 18, 2017

Study Completion Date

April 18, 2017

Conditions

Healthy Volunteers

Interventions

DRUG

[14C]-BGB-3111

20-mg capsule containing \~200 μCi of \[14C\]-BGB-3111,

DRUG

BGB-3111

Three 20-mg capsules of BGB-3111 and three 80-mg capsules of BGB-3111

Trial Locations (1)

Covance Clinical Research Unit, Inc.,, Madison